Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 16,300
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Verde Science, Inc. operates as a pharmaceutical research and development company. It focuses on developing custom medicinal formulations of cannabinoids and THC compounds for the treatment migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in 2014. Verde Science, Inc. was incorporated...
Show more
Verde Science, Inc. operates as a pharmaceutical research and development company. It focuses on developing custom medicinal formulations of cannabinoids and THC compounds for the treatment migraines, glaucoma, loss of appetite from cancer therapies, and other medical issues. The company was formerly known as Rango Energy, Inc. and changed its name to Verde Science, Inc. in 2014. Verde Science, Inc. was incorporated in 2007 and is based in Dallas, Texas.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 888-224-6039
- Website
- https://www.verdescienceinc.com
- Address
- 400 South Zang Boulevard, Suite 812, Dallas, United States
Latest news
No headlines yet.
